Torii Pharmaceutical Co Ltd

Type: Company

Name: Torii Pharmaceutical Co Ltd

First reported May 07 2013 - Updated May 08 2013 - 1 reports

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

NEW YORKAt March 31, 2013, the Company had cash and cash equivalents of $87.3 million, as compared to $14.7 million at December 31, 2012. On January 30, 2013, the Company completed an underwritten public offering of common stock, which provided proceeds ... [Published Bio-Medicine - May 07 2013]

Entities: Keryx Biopharmaceuticals Inc, Zerenex, Citrate

First reported May 06 2013 - Updated May 07 2013 - 3 reports

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results

The Company will host an investor conference call tomorrow, Wednesday, May 8, 2013In order to participate in the conference call, please call 1-877-869-3847 (U.S.), 1-201-689-8261 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference ... [Published Street Insider - May 07 2013]

Entities: Keryx Biopharmaceuticals Inc, Zerenex, Citrate, New Drug Application, Phosphate

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Torii Pharmaceutical Co Ltd Announces Officer Change

7:00am BST Torii Pharmaceutical Co Ltd announced that it has appointed Shoichiro Takagi as President and Representative Director, and Norihiko Matsuo as Chairman of the Board of the Company, effective June 20, 2 ... [Published Reuters UK - Apr 25 2013]

Entities: Torii Pharmaceutical Co Ltd, Appointed

Quotes

Commenting on the quarter, Ron Bentsur, the Company's Chief Executive Officer, said, "Following the announcement of top-line data, we are now focusing our efforts and resources toward the pending NDA and MAA submissions. We are also progressing with the U S PhasePhase 2 CKD study, for which we expect to report top-line data in the third quarter of 2013."

Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results [Published Staten Island Live - May 07 2013]

More Content

sort by: Date \| Relevance
Keryx: A Small Biotech With Catalysts Galore [Published Seeking Alpha - May 08 2013]
Keryx Biopharmaceuticals, Inc. Announces First ... [Published Bio-Medicine - May 07 2013]
Keryx Biopharmaceuticals, Inc. Announces First ... [Published Street Insider - May 07 2013]
Keryx Biopharmaceuticals, Inc. Announces First ... [Published Staten Island Live - May 07 2013]
Keryx Biopharmaceuticals, Inc. To Host Conferen... [Published Street Insider - May 06 2013]
Keryx Biopharmaceuticals, Inc. To Host Conferen... [Published Staten Island Live - May 06 2013]
Torii Pharmaceutical Co Ltd Announces Officer C... [Published Reuters UK - Apr 25 2013]
JT, Torii conclude agreement to market novel an... [Published Japan Today - Aug 29 2012]